Max Robotics — Global Service Robot Directory + US Certification

About

Shahar Lavi is a leading cardiovascular researcher whose work is reshaping the landscape of coronary revascularization, particularly for patients with complex multivessel disease. His primary research focus is the development and optimization of hybrid coronary revascularization (HCR)—a pioneering approach that strategically combines the durability of coronary artery bypass grafting (CABG) with the minimally invasive benefits of percutaneous coronary intervention (PCI). Dr. Lavi’s major contributions include a landmark comparative effectiveness analysis demonstrating the long-term viability of HCR against traditional off-pump CABG, a study that has garnered significant attention with 55 citations. He has also been a key voice in articulating the future potential of this hybrid strategy, exploring its advantages in reducing procedural trauma while maintaining graft and stent patency. Beyond HCR, his work critically examines the nuances of robotic-assisted CABG, identifying the reasons and outcomes associated with conversion to sternotomy. With his research informing safer, more effective surgical decision-making, Dr. Lavi is at the forefront of defining a new, integrated standard of care for coronary artery disease.